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ABSTRACT
MECHANISMS BY WHICH MECHANOTRANSDUCTION
PROMOTES PROLIFERATION IN KERATINOCYTES
CHHAVI CHAUDHARY
2018
Chronic wounds are wounds that do not heal within 30 days and often they can
last over a year. Interference in any of the wound healing stages may hinder the process.
Some of the local and systemic factors such as infection, old age, diabetes, AIDS, and the
regular application of corticoids may also have negative effects on the healing process.
Cell proliferation is an important phase in epidermal wound healing in which surviving
epithelial cells replicate independently into daughter cells through mitosis and maintain a
balance between cell growth and cell loss during the cell cycle. Physical and chemical
stimuli play important roles in regulating cell proliferation through activating intracellular
signal transduction pathways. A physical stimulus which enhances skin cell proliferation
relies on mechanical stretch. However, the mechanism(s) by which cells sense and
respond to mechanical stimulation remain(s) unknown.
Most research regarding sensing of mechanical stimuli emphasizes the role of
cellular membrane proteins including channels, integrins, and receptors for growth
factors. Channels could be selective or non-selective, or mechanosensitive for inorganic
ions or small molecules, with high permeability to ions such as sodium, potassium,
calcium, and magnesium. Mechanosensitive channels (MSCs) are present in many cell
types including epidermal keratinocytes. MSCs play a crucial role as a mechanosensors
which convert mechanical stimuli into electrical or chemical signals. MSCs may affect
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cells through the movement of specific ions, such as calcium, across the plasma
membrane. Cytosolic calcium in the form of steady or transient changes is required for
cell cycle progression, cell proliferation and cell division. In other words, Ca2+ influx is
required for mechanosensitive cell proliferation in human keratinocytes. In this study, we
monitored the proliferation rate of stretched cells and observed that mechanical stretching
induces a higher percentage of keratinocytes into S-phase. Proliferation was reduced or
inhibited in the absence of extracellular Ca2+ or when Ca2+ influx was blocked,
respectively. Many pharmacological inhibitors of MSCs were screened to evaluate their
effect on cell proliferation and the results demonstrate that blockage of the
mechanosensitive ATP channel, pannexin, significantly inhibited proliferation.
Identification of a pathway that promotes proliferation of keratinocytes provides us with a
target for a chemical treatment that speeds proliferation and promotes wound healing.
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INTRODUCTION
Skin is the largest organ of the body and it covers most of the external surface of
the body. It consists of the outermost epidermis and the underlying dermis. Some have
listed the hypodermis, a layer beneath the dermis as a third layer of skin (1). Skin is
supported by several underlying structures including fascia (connective tissue), muscle,
tendons, ligaments, and arterial and venous blood vessels (2). It is a defensive and
sensory barrier between the external environment and the internal organs which protects
against water loss, damaging chemicals, micro-organisms, mechanical stress, and
radiation. Skin has sensory functions related to touch, pressure, temperature, and pain,
and alerts the body to potential tissue damage (3-7).
The epidermis is the outermost layer of the skin comprised of nearly 95%
keratinocytes, but also includes melanocytes, Langerhans cells, and Merkel cells (8). It
works as a waterproof barrier which repels fluids but retains water in the body. Its
thickness varies from 0.07 mm to 0.12 mm, except on the palms and soles, where it varies
from 0.8 mm to 1.4 mm (9). The epidermis does not contain any blood vessels, however,
even the deepest layer of epidermis obtains some O2 which diffuses in from the external
atmosphere.
Cells of the epidermis replicate through mitotic division at the deepest layer and
the cells move superficially to the outermost layer. The cells change shape and
composition during their movement through the epidermis. The outermost layer of the
epidermis is approximately 25 times thicker than the basement membrane layer (10). This
process takes place within weeks. Below is a detailed description of the five different
layers of epidermis from deep to superficial.
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1. The basal layer of epidermis is known as the stratum basale and contains
keratinocytes, melanocytes, and Merkel cells. The keratinocytes, from the lowest layer of
the epidermis, are continually moving to the outermost surface by the production of new
cells beneath them. Keratinocytes fill with keratin as they are pushed to the surface of the
epidermis and this process is known as keratinization.
2. The stratum spinosum is the second layer superficial to the stratum basale
where keratinocytes begin to develop cell-cell junctions and begin producing lamellar
bodies, secretory granules filled with lipids, hydrolytic enzymes, and many other
proteins.
3. In the next layer, the stratum granulosum, keratinocytes lose their nuclei and
the cytoplasm is more packed with lamellar bodies.
4. The stratum corneum is the outermost layer which is made of the mature or
dead keratinocyte epithelium. Keratin protein in the stratum corneum layer moves
superficially and these cells are sloughed off from the surface constantly. The stratum
corneum has an acidic pH, called the acid mantle, which protects the body from some
bacteria and fungi. Most of the barrier function of the epidermis is contained in this outer
most layer.
5. The palms of the hands and the soles of the feet contain a 5th epidermal layer,
called the stratum lucidum, a clear inner layer of the stratum corneum. This layer is made
of dead and flattened cells.
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Epidermal Wounds
Epidermal wounds occur when skin is cut, punctured, or damaged through some
other form of injury such as ischemic injury which occurs during prolonged blood
restriction. Injuries can damage the epidermal and dermal cells, nerves, blood vessels
and other underlying tissues, and even organs. Based on the cause of damage, site, depth,
and duration to heal, wounds can vary from simple to life threatening. According to the
healing time, wounds can be classified as acute or chronic and a descriptive comparison
between these two groups of wounds is listed in Table 1 below (11, 12).
Table 1. Acute vs. chronic wounds.
Parameter
Acute Wound
wounds that heals within
Duration
expected period. e.g. weeks to
months

Chronic wound
wounds that do not heal within
anticipated time. e.g. one
month to three months
signs are noticeable but
unknown or unclear such as
erythema, edema, heat, or
severe inflammation

Symptoms

pain, swelling or bleeding, foul
smelling pus or drainage

Examples

surgical wounds, bites, burns,
abrasions trauma

venous stasis ulcer, diabetic
foot ulcer, bedsores, pressure
ulcer and arterial ulcer

Wound
Assessment

chemical treatment, minimal
mediation, surgical debridement,
antimicrobial therapy

no chemical treatment, wound
dressing, negative pressure
therapy, electrical stimulation

Wound healing requires many important factors to work in a coordinated manner.
Non-healing wounds are wounds which fail to heal through the normal process or in a
timely manner (13). Chronic wounds generally last more than 30 days but can last for
over a year. Multiple factors affect the wound healing process and they can be divided
into two classes depending on their source. First, local factors affect the patient from the
external environment including dehydration of the wound, microbial load, level of
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maceration, necrosis, pressure, trauma, and edema. On the other hand, systemic factors
directly affect the performance of bodily functions through the patient’s own physiology
or condition such as age, gender, diabetes, obesity, hypothyroidism, immunosuppression,
radiation therapy or chemotherapy, macronutrients or micronutrients and smoking (1418).
Chronic wounds are the result of vascular ulcers (e.g., venous and arterial ulcers),
diabetic ulcers, and pressure ulcers (19). Some common features shared by each of these
wounds include prolonged or excessive inflammation (20), persistent infections (21),
formation of drug-resistant microbial biofilms (22), and the inability of dermal and/or
epidermal cells to respond to reparative stimuli (23-25). Altogether, these
pathophysiological phenomena result in the failure of these wounds to heal. The
underlying pathologies, however, differ among various types of chronic wounds.
Chronic wounds have been a major challenge for both patients and the healthcare
system throughout the world. It has been estimated that the annual chronic wound costs
exceed $15 billion with the chronic wounds affecting approximately 2.4–4.5 million
patients, in the United States alone (26-28). It has been reported that the cost to treat
chronic wounds in the USA is 2-3% of the healthcare budget in other developed countries
and it represents approximately 2% of total European Union financial resources, Table 2
(27, 29, 30).
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Table 2. Summary of the impacts of chronic wounds (30)
Type

No. of affected
patients

Cost of treatment

Total annual cost

Venous ulcers

400,000–600,000

$5,000–$10,000

$1.9 - $2.5 billion (31)

Arterial ulcers

100,000 (32)

$9,000–$16,000

Diabetic ulcers

2 million

$6,000/patient

Pressure ulcers

1.3 - 3 million

Up to $70,000
(34)

$150 million
(33)
$3.5 - $7.0 billion
(34)

The chronic wounds listed above are more commonly found in elderly patients
and the elderly population in the USA continues to increase. The number of citizens 65
years or older is expected to nearly double (from 35 million to 53 million people) by
2030 (35) and the estimated risk of developing diabetes for children born in 2000 is as
high as 35% (36). The anticipated risks of diabetes and age-associated nonhealing
chronic wounds continue to increase dramatically, and the estimated chance of diabetes
and age-associated chronic wounds will increase in the future and throughout the world.
The medical treatment for chronic wounds often uses advanced treatments such as
growth factors, extracellular matrices (ECMs), engineered skin, Electrical stimulation
therapy (EST) and negative pressure wound therapy (NPWT) (37). The latter two
treatments have been used to speed the healing of chronic wounds. Both appear to make
use of mechanotransduction pathways to promote healing.
Epidermal Wound Healing
Epidermal wound healing is a crucial and complicated process to repair the
strength and missing portions of the organ to regain structure and function. Four-stages
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are involved in epidermal repair and reconstruction including hemostasis, inflammation,
proliferation, and maturation.
The first phase of healing is known as hemostasis, in which bleeding is stopped.
Platelets bind with collagen outside of the bloodstream to promote platelet plug
formation. The release of other chemical messages promotes activation of clotting
factors, including thrombin, to form the fibrin mesh to prevent further loss of blood.
Preparation of the wound bed for the growth of new tissue is part of the defensive
or inflammatory phase of wound healing. This is done by the process of phagocytosis in
which white blood cells invade the injured site and engulf bacteria and remove foreign
material or debris from the wound within 2 days. Release of growth factors including
platelet derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) are
also released and lead to the beginning of the proliferative phase.
The formation of new blood vessels and filling of the wound bed through
granulation occurs during the very early stage of the proliferative phase. Then,
construction of the wound margin takes place. Migration of epithelial cells from the
edges of the wound toward the center of the wound occurs. The process continues until
the epithelial cells cover the wound completely.
The last phase of wound healing is known as maturation or the remodeling phase.
New tissue is remodeled and matures to attempt to recover the original strength and
flexibility. Unused cells will undergo apoptosis or programmed cell death.
Most cells are sensitive to different forms of mechanical stimuli. Different
physical forces are important for the regulation of cell physiology and pathogenesis of
skin. Mechanotransduction is the process by which cells sense mechanical forces from
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the surrounding environment and convert these physical forces into appropriate
biochemical signals. Forces are required to maintain cell shape and function, during
proliferation, migration, and apoptosis. The mechanosensitive nature of tissues is well
known and is used to help drive development of better medical devices, novel drugs, and
therapies for treating diseases, and novel tissue scaffolds for tissue repair and
reconstruction (38-42).
There are many signaling pathways by which cells respond to mechanical stress.
It is now apparent that there are also multiple types of mechanoreceptors, ranging from
stretch-activated channels in the plasma membrane, to cytoplasmic proteins, and the
nucleus itself undergoes changes in response to force. However, the exact mechanisms
by which a cell senses and reacts to mechanical signals are not entirely unknown. Over
the past few decades, the importance of mechanical signals in tissue development,
homeostasis and repair have been recognized, and the underlying mechanisms are being
actively identified.
Cells are subjected to various combinations of mechanical stimuli in their
physiological environment. Hence, it is difficult to predict which stimulus is responsible
for which change within the cell. To understand the nature of physical forces, 3 different
forces will be discussed, including compression, tension, and shear (43).

Compression

Tension

Figure 1. Different types of mechanical forces.

Shear
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Compression
Compression is known as a pushing force and leads to a decrease in the length of
the object along a specified axis.
Tension
Tension is a pulling force that tends to stretch the material in opposite directions.
An increase in blood pressure increases tension on the endothelial cells while a rapid
increase in weight gain places an increase in tension on the epidermis. Stretching of
epidermal keratinocytes promotes proliferation to reduce the stretching force (44-47).
A common way to apply tension to cells is to seed them on a stretchable surface.
After cells have adhered to the stretchable surface, the substrate is stretched in opposite
directions from two ends and the adherent cells become stretched as well.
Shear
Shear is a force which tends to slide one face of an object over an adjacent face.
It can bend or twist the object. The endothelial cells lining blood vessels are subject to
shear stresses produced by blood flow (48).
The process of cellular mechanotransduction is divide into three stages:
(i)

Mechanoreception: Detection of the stimulus and transmission of the signal from

outside the cell to the inside.
(ii)

Intracellular signal transduction: Transduction of mechanical stimulus into

biological signals in the cell where a series of signaling response can be generated. The
intracellular signal is transmitted by second messengers, and a network of intracellular
signaling proteins.
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(iii)

Target activation: Activation of proteins that causes changes in cell structure and

function in response to stretch.
Mechanoreceptors respond to extracellular physical signals and transmit these
extracellular stimuli from the outside of the cell to the inside. Mechanoreceptors are
commonly present in the cell membrane including (i) integrins, (ii) mechanosensitive or
stretch-activated channels, and (iii) other cell-surface receptor proteins. This thesis will
emphasize plasma membrane, mechanosensitive channels.
Mechanosensitive Channels
Mechanosensitive or stretch-activated channels (49-54) are proteins that span the
plasma membrane, connecting the cytosol to the cell exterior. The permeability of ion
channels is highly controlled. However, while some channels are most permeable to only
one ion e.g. Na+, K+, Ca2+, and Cl−, some are non-selective and allow multiple cations or
anions to pass through, while others allow passage of small organic molecules. In the
resting state many mechanosensitive channels are usually closed. Introduction of a
mechanical stimulus shifts the channels to an open state and ions or molecules move
down their electrochemical gradient. Mechanosensitive ion channels are the sensors for
several systems including the senses of touch, hearing, and balance, as well as
participating in cardiovascular regulation and osmotic homeostasis (55-57).
Based on the permeability of ions, mechanosensitive ion channels can be divided
into different groups. Cation-selective MSCs show a selective permeability for positive
ions such as Na+, K+ and Ca2+. They exhibit a small single channel conductance range of
25-35 pS (54). These cation-selective MSCs are blocked by the trivalent gadolinium ion.
Anion selective MSCs are permeable for negative ions and generally contain a large
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conductance (> 300pS). Non selective ion channels are found in the Archaea and
prokaryotes, and rarely in Eukarya (58).
Examples of Mechanosensitive channels in Eukaryotes 1.

ENaC/DEG superfamily (59)

2.

TRP superfamily: There are seven subfamilies within the TRP superfamily:

TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPP (polycystin),
TRPML(mucolipin), TRPA (ankyrin), and TRPN (NOMPC-like) (59)
3.

Piezo1 and Piezo2 (60)

4.

Pannexin (61)
Cells are mechanically stimulated through several major interrelated pathways

which include integrin–matrix interactions, cytoskeletal strain, and membrane stress. Two
mechanisms are supposed to be responsible for the opening of mechanically gated ion
channels. First, the conformation of ion channels is modified in response to applied
forces that affect the membrane-embedded proteins. This is known as lipid bilayer
tension or the stretch method (62, 63). Second, stretch activated channels have an ability
to be deformed by the actin cytoskeleton or extracellular matrix which is attached to the
stretch-activated channel and they directly regulate the opening of ion channels (55, 64).
This process is known as the spring-like tether model. In addition, mechanosensitive
channels control calcium-dependent pathways that further regulate intracellular
signaling and cytoskeletal remodeling (65-67).
Mechanical Forces Promotes Cell Proliferation
Mechanical forces regulate various phases of the cell cycle which include the
onset of mitosis. Researchers found that the tension and mechanical energy of a tissue
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could anticipate the regulation and duration of the phase G1–S transition and mitotic
rounding. Cells that experience the higher intercellular tension exhibit a higher
probability to transition from G1 to S, as well as a shorter G1 and shorter S–G2–M
phases. It is also found that tension increases during the cell cycle but decreases
3 hours before mitosis to facilitate the process of mitosis. In addition, neighboring cells
collaborate in this process before and during division (44-47).
The research in this thesis will be directed toward understanding the Ca2+ influx
pathway that is used by keratinocytes to promote proliferation. Cells cultured on a
flexible silicone membrane, will be stretched and multiple pharmacological blockers will
be screened to help identify this pathway. We hypothesize that the pathway that is used
to promote keratinocyte proliferation, could be stimulated chemically to help promote
cellular proliferation and speed wound closure.
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MATERIALS AND METHODS
Cell Culture
Clonal human epidermal keratinocytes, HaCaT, were maintained in Dulbecco's
Modified Eagle Medium (DMEM, Gibco, Fisher Scientific) containing 10% Fetal Bovine
Serum (Gibco, Fisher Scientific), 1% of 10,000 index units of penicillin-streptomycin
solution. Cells were cultured in a 5% CO2, 37o C, humidified incubator. For
experimentation, cells were seeded on polydimethylsiloxane (PDMS) chambers in normal
DMEM medium (Appendix A) for 24 hrs. Optimum cell density for seeding the cells on
the PDMS chambers was ~1x105 cells/ml). Cell density was determined prior to seeding
the PDMS chambers by counting cells with a hemocytometer.
Preparation of Cell Suspension for Splitting or Transferring Cells
Removing cells from the bottom of the tissue culture flask prior to splitting the
culture to a different flask or prior to seeding cells in the PDMS chambers required gentle
removal of those cells using a trypsin-EDTA solution. EDTA chelates divalent ions and
loosens cells from the bottom of the dish while trypsin, a protease, cuts protein
connections between the cells and the bottom of the flask. The protocol below is used to
prepare the cell suspension:
1. Gradually remove the DMEM from flask with adherent cells.
2. Rinse cells with brief treatment, < 20 s, of 2 ml of 0.25% trypsin-EDTA.
3. Add 2 ml of 0.25% trypsin-EDTA and keep in incubator for 3-5 mins to dissociate
adherent cells from the bottom of the flask.
4. Add 10 ml of DMEM to halt trypsin activity.
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5. Gently transfer the cells into a 15 mL conical tube and centrifuge the cells at 800-1000
rpm, 5 mins, to pellet the cells and remove dilute trypsin-EDTA.
6. Remove the dilute trypsin-EDTA and DMEM from the conical tube.
7. Submerge the cell pellet with 1mL of DMEM and gently resuspend the cells.
Counting Cells with the Hemocytometer
Cell numbers are determined by using a hemocytometer. Hemocytometers are
essentially a grid, etched into a glass slide with a coverslip placed a known distance from
the bottom of the slide (Figure 2). Therefore, a 2D cell count can be calculated to determine
a 3D cell density.

Figure 2. Example of a hemocytometer.
(“Hemocytometer” by Matt Janicki. CC BY 2.0. https://creativecommons.org/licenses/by/2.0/#)

The following protocol is used to prepare and count cells on a hemocytometer.
1. Hemocytometer and glass coverslip should be cleaned with ethanol before use.
2. Place 10 μl of 5x diluted cell suspension on the hemocytometer grid and cover with
coverslip.
3. Using an upright microscope, focus on the grid lines of the small, internal squares with
a 10x microscope objective.
4. Count the live cells within 16 small squares (4 by 4 squares) with volume of 4 nL.
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5.

Move the hemocytometer and count 3 addition 4 by 4 boxes, along the corners of the
hemocytometer grid.

6. Take the average of cells from all of the regions.
7. Divide by 4 x 10 -6 mL to obtain cells/mL and multiply by 5 to correct for the dilution.
8. The final cell count is the number of viable cells per ml in the original cell suspension.
Preparation of Silicone Chambers
The SYLGARD ® 184, silicone elastomer kit (Dow Corning) is used to prepare the
PDMS chambers. PDMS chambers (68) were prepared by mixing, uncured polymer and
curing reagent in [10: 0.86 (w/w)] for 10-15 s. The mixture was degassed at room
temperature and cured at 37°C overnight in a plastic mold (Figure 3). The mold includes
removable aluminum pylons in order to enable attachment to a stretching rack.
Additionally, small rectangular pieces of polycarbonate were inserted in the bottom of the
mold prior to PDMS in order to fabricate a well in the PDMS chamber (Figure 3). After
curing, chambers were treated to enable cell adhesion to the hydrophobic silicone.
Surface Modification of PDMS Chambers
The hydrophobic silicone surface was made more hydrophilic through oxidation
with piranha solution, a mixture of concentrated H2SO4 and 30% H2O2 in a 3:1 ratio (69).
This mixture is exothermic and was allowed to cool to room temperature before applying
on chambers. Over oxidation of the chambers caused an opaque surface and even rippling
at higher oxidation which made imaging of cells difficult. Also curing times varied with
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PDMS mold

PDMS chamber

Stretching Rack

Figure 3. PDMS chamber mold, finished PDMS chamber and stretching rack.

The pylons of the stretching rack are 10% further apart than the pylons in the mold so that
when the chamber is mounted on the rack, the PDMS will be stretched by 10% different
batches of the purchased starting materials. Therefore, a test oxidation was performed for
each batch. A successful test was determined by the absence of opaqueness after oxidation
when dried. As a result, oxidation with piranha solution varied from 30s to 5 mins at room
temperature. After oxidation, chambers were rinsed with DI water.
To ensure removal of oxidation products and piranha solution from the chambers
they were soaked in DI water for 10 mins in repetition. PDMS is porous and repetition of
this process enhanced cellular adhesion on the chambers.
Silicone Chamber Sterilization and Coating with Collagen
Cell adhesion was enhanced through collagen coatings. Chambers were sterilized
with 70% ethanol and allowed to dry for 30 mins in a sterile, laminar flow hood. Collagen
(Advanced Biomaterial Pure Collagen type I) was diluted in sterile filtered, DI water, 1:30
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(v/v). The mixture was spread on the chambers in order to allow the collagen protein to
bind on the chambers at room temperature for 2-3 hours (68). Fluid was removed and the
chambers were allowed to air dry in the sterile hood for 30-60 mins. Collagen coated
chambers were used immediately after drying or stored at 2-8°C until use. Before
introducing cells, collagen coated chambers were gently rinsed with PBS or culture
medium to remove any nonadherent collagen and to ensure neutral pH during cell adhesion.
A step by step protocol for chamber preparation is provided in Appendix B.
Stretch-Induced Cell Proliferation Assay
HaCaT cells were plated on sterilized and collagen-coated, PDMS chambers with
similar cell density so that cells could grow on the chamber surface for 48 hours. Cells
were initially plated in DMEM to inactivate residual trypsin and enhance adhesion. After
4 hrs incubation, unattached cells were removed by washing with fresh Hank’s media (70)
and adherent cells were incubated for 24 hours at 37°C before stretching (71). During
experiments, cells were stretched on aluminum stretching racks (Figure 3) and fresh Hank’s
media was added to the chambers. Overnight cultures of cells were exposed to unstretched
and stretched conditions in attempts to identify the mechanosensitive signaling pathway
which promotes cell proliferation. Three hours before the end of the 24 hour stretching
period (68), the EdU (5-ethynyl-2'-deoxyuridine) reagent was added on the chambers. EdU
is a nucleoside, a thymidine analog which has been chemically modified for easy
fluorescent tagging. Cells in the proliferation phase of the cell cycle incorporate EdU into
their nuclei during DNA replication. The EdU reagent enables identification of the relative
numbers of cells within the S-phase of the cell cycle which precedes mitosis.
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Preparation of Hank’s Balanced Salt Solution (HBSS)
Serum free, HBSS was used during experimentation as HaCaT cells show a 2.5fold increase in proliferation during 10% stretch in HBSS (70, 71). HBSS was made by
adding each of the components from Table 3. Media was filter sterilized and stored at 4oC
in the refrigerator.
Table 3. Composition of HBSS (1L).
Component
NaCl (mw: 58.4 g/mol)
KCl (mw: 74.6 g/mol)
CaCl2 (mw: 111.0 g/mol)
MgSO4-7H2O (mw: 246. 5 g/mol)
MgCl2-6H2O (mw: 203.3 g/mol)
Na2HPO4 (mw: 178.0 g/mol)
KH2PO4 (mw: 136.1 g/mol)
Glucose (mw: 180.2 g/mol)
NaHCO3 (mw: 84.0 g/mol)

Mass
8g
400 mg
140 mg
100 mg
100 mg
60 mg
60 mg
1g
350 mg

Molarity
0.14 M
0.005 M
0.001 M
0.0004 M
0.0005 M
0.0003 M
0.0004 M
0.006 M
0.004 M

Pharmacological Blockers
Pharmacological blockers of mechanosensitive channels were added in the culture
media in attempts to block stretch-induced proliferation. Blockers were made as stock
solutions in aqueous media or dimethyl sulfoxide (DMSO) for the more hydrophobic
agents (Appendix A). For example, a 10 mM stock solution of amiloride was dissolved in
DMSO and diluted in HBSS prior to experimentation to obtain a final working
concentration of 10 μM. Other compounds were diluted to final working concentrations
listed in Table 4.
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Table 4. List of pharmacological blockers of mechanosensitive channels.
Blocker
Channel
Working Concentration
Amiloride (72)
Epithelial Na+ channel
10 μM
Carbenoxolone (73)
pannexin
100 μM
Gadolinium (III) chloride (74)
nonspecific
10 μM
MK-886 (75)
TRPM7
20 μM
ML-204 (76)
TRPC4
10 μM
RN1734 (67)
TRPV4
30 μM

In addition to specific blockers of mechanosensitive channels, nonspecific blockers
of Ca2+ signaling were used during positive control experiments. EGTA, a selective
chelator for Ca2+, was used to remove Ca2+ from the media. The composition of Ca2+ free
HBSS is given in Table 5.
Table 5. Composition of Ca2+-free HBSS (0.1L).
Component
Mass
NaCl (mw: 58.4 g/mol)
0.8 g
KCl (mw: 74.551 g/mol)
40 mg
EGTA (mw: 380.35 g/mol)
38.035 mg
MgSO4-7H2O (mw: 246.475 g/mol)
10.0 mg
MgCl2-6H2O (mw: 203.303 g/mol)
10.0 mg
Na2HPO4 (mw: 177.99 g/mol)
6.0 mg
KH2PO4 (mw: 136.086 g/mol)
6.0 mg
Glucose (mw: 180.156 g/mol)
0.1 g
NaHCO3 (mw: 84.007 g/mol)
35 mg

Molarity
0.14 M
0.005 M
0.001 M
0.0004 M
0.0005 M
0.0003 M
0.0004 M
0.006 M
0.004 M

Cell Fixation and Permeabilization
At the end of the 24 hour experimental period, both control and experimental cells
in the silicone chambers were fixed for 15 min. using 3.7% paraformaldehyde in PBS.
Cells were permeabilized for 20 min. with PBST (0.1% Triton X-100 in PBS) to enable
penetration of the reagents in the EdU kit.
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Fluorescence Labelling of S-Phase Cells
Cell proliferation is measured by identifying cells in S-phase of the cell cycle i.e.
the DNA synthesis phase, using the Edu Click-iT® kit (Invitrogen). The EdU contains the
alkyne and the Alexa Fluor® dye contains the azide. A click-chemistry reaction works,
when a copper-catalyzed covalent reaction occurs between an azide and an alkyne.
Additionally, standard aldehyde fixation and detergent based permeabilization are
compulsory for the Click-iT® detection reagent. The detergent removes lipids and helps to
increase access to the DNA for the two fluorescent stains. The Click-iT® EdU assay is
useful to produce low background and high detection sensitivities. The components of the
kit were assembled, used and stored according to manufacturer’s instructions. A step by
step protocol is provided in Appendix C.
Immunofluorescence and Image Analysis
Stained cells were visualized using widefield fluorescence microscopy with an
Olympus BX-50 system (Cell Sens standard v1.14). The EdU labeled DNA was visualized
using the TRITC filter cube while the Hoechst fluorescent DNA stain was visualized using
the DAPI filter cube which has similar excitation and emission spectra. Images were
processed and analyzed. Cells in S-phase, staining red, were compared to the total number
of cells in a field of view, with blue, Hoechst-stained, nuclei. The ratio of S-phase cells to
all cells in the fields of view were compared for the different treatments and a Students
two-tailed t-test was used to assess statistical significance.
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In-silico Identification of Mechanosensitive Channels in Human Keratinocytes
A human keratinocyte transcriptome (77) was downloaded, annotated and
screened for mechanosensitive channels. The transcriptome screened human fibroblasts,
melanocytes, and keratinocytes for 22582 genes from the human genome and reported at
least one transcript for 19161 genes from 4 different screenings of human keratinocytes.
Transcripts were arranged according to their reads per kilobase of transcript per million
mapped reads (RPKM), a normalized unit of transcript expression. The BioMart program
was then used to identify the gene name for all the ensemble identifiers. First, all
channels were sorted from the large list of transcripts. Second, MSCs s were and Ca2+
permeable channels were extracted and listed from highest RPKM to lowest RPKM in
Table 6.
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RESULTS
Identification of Mechanosensitive Channels in Human Keratinocytes
Stretch-induced cellular proliferation in keratinocytes requires Ca2+ influx. In
order to identify the most abundant mechanosensitive ion channels in human
keratinocytes and other mechanosensitive, Ca2+-dependent pathways, a human
keratinocyte transcriptome (77) was downloaded and screened for the transcripts of
interest. The transcriptome listed 22,582 transcripts from human keratinocytes according
to reads per kilobase of transcript, per million mapped reads (RPKM) a relative measure
of transcript quantity.
309 out of 22,582 transcripts are identified as membrane channels permeable to
Na+, K+, Ca2+, Cl-, Zn2+, H+, water (aquaporins) and small organics. Furthermore, 91
transcripts out of the 309 are transcripts for Ca2+ permeable channels, their associated
proteins, and associated factors. Transcripts for MSCs, Ca2+ permeable channels, their
associated proteins, and associated factors are arranged in order of most abundant
transcript to least abundant in Table 6 below for RPKM values ≥ 0.5. An extension of
Table 6 is listed in Appendix D for transcripts with lower RPKM values. According to
this list TRPM7, Piezo1, TRPV3, polycystic 2 (TRPP2), polycystic 1 (TRPP1), TRPM8,
TRPM1, TRPV2, TRPM4 and the epithelial Na+ channel have RPKM values greater than
1. A transcript for Pannexin 1, a mechanosensitive ATP release channel which activates
purinergic receptors is the 2nd most abundant. Numerous purinergic channels are present
including P2X4, P2X7, P2Y1 and P2Y11. Therefore, activation of pannexin which
releases ATP could increase Ca2+ influx through purinergic receptors. These influx
pathways will be tested to determine their relevance in keratinocyte proliferation.
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Table 6. Transcripts for Ca2+ influx pathways.
Ensemble ID
ENSG00000092439
ENSG00000110218
ENSG00000103335
ENSG00000196557
ENSG00000167723
ENSG00000118762
ENSG00000008710
ENSG00000135124
ENSG00000198420
ENSG00000107614
ENSG00000134160
ENSG00000187688
ENSG00000130529
ENSG00000111319
ENSG00000089041
ENSG00000169860
ENSG00000167535
ENSG00000160325
ENSG00000168447
ENSG00000144935
ENSG00000078795
ENSG00000244165
ENSG00000170379

Annotation
transient receptor potential cation channel subfamily M
member 7 [Acc:HGNC:17994]
pannexin 1
[Acc:HGNC:8599]
piezo type mechanosensitive ion channel component 1
[Acc:HGNC:28993]
calcium voltage-gated channel subunit alpha1 H
[Acc:HGNC:1395]
transient receptor potential cation channel subfamily V
member 3 [Acc:HGNC:18084]
polycystin 2, transient receptor potential cation channel
[Acc:HGNC:9009]
polycystin 1, transient receptor potential channel interacting
[Acc:HGNC:9008]
purinergic receptor P2X4
[Acc:HGNC:8535]
TRPM8 channel associated factor 1
[Acc:HGNC:22201]
polycystin 2 like 1, transient receptor potential cation
channel [Acc:HGNC:9011]
transient receptor potential cation channel subfamily M
member 1 [Acc:HGNC:7146]
transient receptor potential cation channel subfamily V
member 2 [Acc:HGNC:18082]
transient receptor potential cation channel subfamily M
member 4 [Acc:HGNC:17993]
sodium channel epithelial 1 alpha subunit
[Acc:HGNC:10599]
purinergic receptor P2X 7
[Acc:HGNC:8537]
purinergic receptor P2Y1
[Acc:HGNC:8539]
calcium voltage-gated channel auxiliary subunit beta 3
[Acc:HGNC:1403]
calcium channel flower domain containing 1
[Acc:HGNC:1365]
sodium channel epithelial 1 beta subunit
[Acc:HGNC:10600]
transient receptor potential cation channel subfamily C
member 1 [Acc:HGNC:12333]
polycystin 2 like 2, transient receptor potential cation
channel [Acc:HGNC:9012]
purinergic receptor P2Y11
[Acc:HGNC:8540]
TRPM8 channel associated factor 2
[Acc:HGNC:26878]

Transcript
(RPKM)
14.2
9.5
3.7
3.5
3.3
3.0
2.7
2.3
2.1
1.6
1.6
1.6
1.3
1.2
1.1
1.0
0.9
0.8
0.8
0.8
0.5
0.5
0.5
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Tensile Stress Promotes Keratinocyte Proliferation
Cell proliferation of a clonal, human epidermal keratinocyte cell line (HaCaT)
was monitored during application of tensile stress. Proliferation was monitored under
stretched and unstretched conditions. Under stretched conditions keratinocytes were
subjected to one-dimensional tensile stress by increasing their length by 10% on silicone
chambers for 24 h. Control cells were grown on the same silicone chambers without
stretch. Cell proliferation was quantitated by monitoring EdU incorporation during the
last 3 hours of experimentation.
Four independent unstretched chambers were seeded with HaCaTs, (Figure 4A).
After the experimental incubation period, cells were fixed and the EdU was stained with
the Click-IT method (Figure 4B) to identify cells in the proliferative state and all nuclei
were stained with Hoechst (Figure 4C), in order to count all cells in the field of view.
The proliferation rate (number of EdU labeled cells/ Hoechst labeled cells) was
normalized to 100% (Figure 5). Stretching of six independent silicone chambers, seeded
with HaCaTs, increased the number of cells in S-phase to 198% compared to the
unstretched controls (Figure 5), with a high statistical significance (p < 0.0001).
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A

B

C

Figure 4. Images of human keratinocytes and labelled keratinocyte nuclei. (A) HaCaT
cells, visualized with phase contrast, adhere well to the collagen-functionalized silicone
chambers. (B) EdU incorporated into the nuclei was stained with Alexa Fluor 555. (C)
Hoechst 33342 was used to stain all cellular nuclei. The images in B and C are collected
from the same chamber.
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Figure 5. Stretching cells promotes the proliferative state. Stretching cells by 10% of their
initial length, places twice as many cells in the proliferative state compared to unstretched
conditions. (*** = p < 0.0001).
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Stretch-Induced Proliferation Requires Ca2+ Influx
Previous studies have indicated that Ca2+ influx is required for cellular
proliferation (68, 78-80). We tested these former results in order to confirm them in our
system (Figure 6). Ca2+ was removed from the extracellular medium by first not adding
it to the culture media and second by buffering any remaining Ca2+ with EGTA (1mM).
Ca2+ influx through plasma membrane Ca2+ channels was blocked with the non-selective
channel blocker gadolinium (10 μM). In the presence of normal extracellular Ca2+,
stretched cells proliferated nearly 2-fold greater than unstretched cells (Figure 6).
However, reduced extracellular Ca2+ (EGTA), reduced proliferation (p < 0.02). By
blocking Ca2+ influx with the Ca2+ channel blocker, Gd3+, proliferation was also impaired
(Figure 6, p < 0.001).
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Figure 6. Impairing Ca2+ influx reduces proliferation of stretched cells. Removing
extracellular Ca2+ and buffering remaining Ca2+ with EGTA significantly reduced
proliferation. The non-selective Ca2+ channel blocker, Gd3+, also impaired proliferation.
(* = p < 0.05, *** = p < 0.001)
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DMSO Reduces Proliferation
DMSO is an amphiphilic solvent that promotes solubilization of hydrophobic
pharmacological agents. It was required to dissolve some of the pharmacological agents
in the culture media. However, 0.1% DMSO, a low concentration that normally does not
affect cell function, impaired proliferation of HaCaTs. In the presence of 10% stretch and
0.1% DMSO (Figure 7), proliferation was no greater than in the unstretched state.
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Figure 7. DMSO decreases stretch-activated proliferation. 0.1% DMSO completely
nullifies the increased proliferation due to 10% stretch. (*** = p < 0.001)

Pharmacological agents with high selectivity for blocking specific
mechanosensitive, Ca2+ permeable channels were selected to block Ca2+ influx and assess
proliferation in the stretched state. 0.1% DMSO was used as a control but did have a
dramatic effect on cells itself, as noted above. Stock solutions of amiloride, RN1734,
ML204 and MK-886 were dissolved in DMSO. Final concentrations of the compounds
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were used that are known to block greater than 90% of the channels including
amiloride (10 μM), RN1734 (30 μM), MK886 (20 μM), ML204 (10 μM). However,
when compared to the 0.1% DMSO control itself, none of the pharmacological agents
caused statistically significant reduction in the proliferation in the 10% stretched
condition.
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Figure 8. Effect of pharmacological drugs and DMSO on HaCaT proliferation. When
compared to DMSO neither amiloride, blocker of the epithelial Na+ channel, nor
RN1734, blocker of TRPV4, nor MK886, blocker of TRPM7, nor ML204,
blocker of TRPC4 inhibited proliferation.

Pharmacological inhibition of pannexin 1, the channel with the 2nd greatest
RPKM in human keratinocytes, Table 6, was performed with 100 μM carbenoxolone in
the absence of DMSO, as it is a hydrophilic compound. Pannexin 1 is an ATP release
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channel. Released ATP can activate Ca2+ influx through local purinergic channels which
are also present in Table 6. Carbenoxolone significantly impaired cellular proliferation in
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response to 10% stretch.

250
200
150
100

***
50
0

Stretch

CBX

Figure 9. Blocking the pannexin channel inhibits cell proliferation. (p < 0.001).
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DISCUSSION
Human keratinocytes are highly sensitive to tensile stress and respond by
increasing DNA synthesis in preparation for cell division, to reduce the tensile stress. As
a result, tensile stress induces cell proliferation as shown earlier (68, 70). We confirm
that continuous mechanical stretching of keratinocytes by +10% for 24 hrs. significantly
promotes DNA replication when compared to unstretched controls, Fig. 5, (p < 0.0001).
In the stretched condition, the number of cells in S-phase during the final 3 hours of
stretching, monitored by using EdU incorporation in HaCaT nuclei, nearly doubled
compared to unstretched controls.
Calcium channel activation on the cell membrane and calcium influx is crucial for
promoting cellular proliferation especially under the stretched condition (68, 70). In
order to confirm these earlier reports and assess the reliability of our setup, we impaired
Ca2+ influx by removing it from the medium and by using a non-selective Ca2+ channel
blocker, Gd3+. The Ca2+ reaction was significantly inhibited in Ca2+-free solution (1 mM
EGTA), although not as much as anticipated. Under these conditions the free Ca2+
concentration can only be estimated and no Ca2+ concentration measurements were
performed. Reducing extracellular Ca2+ even further with 2 mM EGTA may provoke a
larger response. The addition of Gd3+ (10 μM), in the stretched state, reduced
proliferation to about 65% of the proliferation in the unstretched state. We conclude that
increased HaCaT proliferation due to stretch is dependent on Ca2+ influx from the
extracellular medium.
In order to assess the Ca2+ influx pathway which leads to proliferation, we
collected a human keratinocyte transcriptome, identified all of the transcripts and filtered
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the transcripts in 2 steps: first, identification of all plasma membrane channels, second,
identification of all channels with Ca2+ permeability or that were linked to
mechanosensitive Ca2+ influx. That list, shown in Table 6 was used to select the channels
with the highest RPKM values as we hypothesize that those would have the greatest
impact on cellular function if they were impaired. Table 6 was used only as a guide as
protein levels are not directly proportional to transcript levels.
We performed pharmacological inhibition of some of the top channels in Table 4,
including TRPM7 (RPKM 14.2) and pannexin (RPKM 9.5) and other channels
commonly found in keratinocytes for which pharmacological inhibitors were
commercially available including epithelial Na+ channels, alpha subunit (RPKM 1.2) and
beta subunit (RPKM 0.8) and TRPV4 which is closely related to TRPV3 (RPKM 3.3)
and TRPV2 (RPKM 1.6). Unfortunately, there is no specific inhibitor for the
mechanosensitive channel Piezo 1 which had the 3rd largest RPKM value in
keratinocytes.
Most of the blockers had hydrophobic properties and were dissolved in DMSO to
increase their solubility in aqueous media. When we assessed the influence of DMSO on
cellular proliferation we were surprised to learn that it suppressed cell proliferation at the
low concentration of 0.1%. We hypothesize that DMSO may have influenced
proliferation by reducing stretch in the membrane. DMSO is lipophilic and therefore
partitions within the plasma membrane. The 10% stretch of the plasma membrane may
have been offset by the inclusion of the DMSO into the membrane, thus decreasing
tension in the membrane and reducing channel activation. This hypothesis should be
tested further.
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Pharmacological inhibition of TRPM7, TRPV4, TRPC4 and ENaC had no effect
on proliferation in comparison to the DMSO control, which was used as a carrier for
these compounds. By contrast, inhibition of pannexin by CBX, had a significant affect in
inhibiting proliferation. Pannexin however, is not a mechanosensitive Ca2+ channel. It is
a mechanosensitive ATP release channel (80-83). ATP is known to promote cellular
proliferation in other cell types (84-86). In keratinocytes, ATP release by pannexin
channels can activate purinergic channels which are also found in keratinocytes as
indicated by Table 6. P2X4 and P2X7 are ligand gated Ca2+ permeable channels that
open in response to extracellular ATP (61, 87, 88). The P2Y1 and P2Y11 channels are
also activated by ATP and lead to a rise in intracellular Ca2+ (89, 90).
We hypothesize that mechanotransduction promotes proliferation of human
epidermal keratinocytes by activating an ATP channel, pannexin, which promotes a rise
in intracellular Ca2+. Considering that our hypothesis involves purinergic channels, we
can further test our hypothesis by blocking the purinergic receptors with known
inhibitors. These experiments could be followed up by performing concentration
dependent response curves for the channel blockers and possibly by performing channel
knockdown experiments to remove critical proteins involved with the stretch-induced
proliferation pathway.
These results are useful for explaining the changes made by tensile stress in
keratinocytes during wound healing. The epidermis makes use of tensile stress to
determine whether more or fewer cells are required to cover the entire body. Increased
tensile stress indicates an epidermis with a larger surface area is required while less stress
indicates a lower surface area is required and cells are extruded from the epithelium (91).
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By identifying pharmacological activators of this mechanosensitive pathway, we could
speed wound healing by promoting proliferation of the cells to cover the wound bed. This
study also helps to clarify the role of the multiple different Ca2+ permeable channels in
human keratinocytes.
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APPENDIX A
This appendix lists the full composition of DMEM culture medium and the stock
solutions of pharmacological inhibitors used in the experiments. All the media was sterile
filtered and kept in refrigerator at 2-8 °C. Stock solutions were also kept at 2-8 °C
Table 7. Composition of DMEM culture medium.
Component

Amount

Concentration

DMEM (Gibco™ DMEM)

1 packet

High Glucose

DI H2O

1000 mL

FBS

100 mL

NaHCO3 (mw: 84.007 g/mol)

3.7 g

Pen-strep

10 mL

10%
10,000 U/mL

Table 8. Stock solutions of pharmacological inhibitors.
Blockers
Amiloride
ML-204
CBX
Gd+3
MK-886
RN1734

Amount

Solvent

5 mg
2.26 mg
0.615mg
26.36 mg
2.36 mg
0.6

1.88 mL DMSO
1 mL DMSO
1 mL Hank's Medium
1 mL water
250 µL DMSO
DMSO
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APPENDIX B
This appendix describes the step by step protocol for the preparation of the
silicone chambers and surface modification of chambers
Preparation of silicon chambers:
SYLGARD ® 184 Silicone elastomer kit is used to prepare the PDMS chambers.
1. Weight the base and curing reagents in [10: 0.86 (w/w)].
2. Mix them well for 10-15 sec.
3. Pour the mixture into the chamber molds
4. The mixture was degassed at room temperature for 2-3 hrs. within chamber molds.
5. Chamber molds were baked at 37°C for overnight in dry hot air oven.
6. Chambers must be at room temperature for 30 mins.
7. Gently take the chambers off from the chamber mold.
8. Keep them in clean and dry place.
Protocol for surface modification of chambers
1. Measure Conc. (90%) Sulfuric acid and (30%) Hydrogen peroxide in 3:1 ratio
carefully.
2. Carefully, mixing the Conc. H2SO4 and 30 % H2O2 together. This mixture
produces heat at room temperature and generate an exothermic reaction.
3. Allow the mixture to cool down at room temperature before applying on
chambers.
4. Cured PDMS chambers were treated with piranha solution for 2 mins at room
temperature and washed with water.
5. Soaking the chambers will get better cell adhesion on the chambers.
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6. Chambers were filled with DI water.
7.

Keep the chambers in the same stages for 10 mins.

8.

Repeat the same process twice to remove the proper chemicals from the
chambers.

46
APPENDIX C
This appendix describes the methods for using the Click-iT® EDU Alexa Fluor
555 Imaging kit solution. All the vials must be at room temperature before opening and
all the stock solution must keep at deep freezer or refrigerator.
Table 9. Stock solutions of Click-iT® kit components.
Name
10 mM EdU
Alexa Fluor® azide
DMSO
EdU reaction buffer
EdU buffer additive (10 x)
Hoechst 33342

Component
A
B
C
D
F
G

Solvent
2 mL DMSO
70 µL DMSO
n.a.
36 mL DI H2O
2 mL DI H2O
n.a.

Table 10. Composition of Click-iT® kit cocktails for 10 chambers
Component
Dilution
Required amount
1X Click-iT® EdU reaction buffer
180 µL + 1620 µL
1800 µL
CuSo4
80 µL
80 µL
Alexa Fluor® azide
5 µL
5 µL
Click-iT® EdU buffer additive
20 µL + 180 µL
200 µL
Total amount
2085 µL
2ml

Protocol to use Click-iT® EDU Alexa Fluor 555 Imaging kit solution.
1. Remove the medium from the chambers.
2. Add 1 ml of 3.7 % Paraformaldehyde into the chambers and incubate them for 15
mins at room temperature.
3. Remove the fixative solution and wash the solution with 3% BSA dissolved in
PBS two times.
4. Add of 1 ml of 0.5 % Triton X-100 in PBS into the chambers and incubate the
chambers for 20 mins.
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5. Prepare the cocktail from the stock solution for 10 chambers.
6. Remove the permeabilizing solution from the chambers and wash with 3% BSA
dissolved in PBS two times.
7. Add the 200 μl of cocktails in each chambers and cover with coverslip.
8. Keep the chambers in a dark place.
9. Incubate the chambers for 45 mins at room temperature.
10. Remove the cocktail mixture and wash the chambers with 3% BSA dissolved in
PBS, one time.
11. Remove the wash solution and wash the chambers with PBS one time.
12. Prepare Hoechst Dye 33342 by adding 1 ul of dye to 2 ml of PBS and mix it.
13. Add 200 μl of solution onto the chambers and cover it with coverslip.
14. Keep the chambers in a dark place.
15. Incubate the chambers for 45 mins at room temperature.
16. Remove the solution from chambers and wash the chambers with PBS one time.
17. Add the mounting media and let them dry overnight.
18. Chambers are ready for capturing the image through Brightfield BX-50
fluorescence microscopy system.
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APPENDIX D
This appendix lists the extended identification of plasma membrane channels in
human keratinocytes.
Table 11. Transcripts for Ca2+ influx pathways (extended)
Gene Stable ID

Gene description

ENSG0000010245
2
ENSG0000015395
6
ENSG0000016599
5
ENSG0000017163
1
ENSG0000011088
1
ENSG0000014240
8
ENSG0000000628
3
ENSG0000014840
8
ENSG0000010200
1
ENSG0000008345
4
ENSG0000011912
1
ENSG0000017559
1
ENSG0000019821
6
ENSG0000006719
1
ENSG0000021319
9
ENSG0000014448
1
ENSG0000016257
2

Sodium leak channel, non-selective
[Acc:HGNC:19082]
Calcium voltage-gated channel auxiliary subunit
alpha2delta 1 [Acc:HGNC:1399]
Calcium voltage-gated channel auxiliary subunit
beta 2 [Acc:HGNC:1402]
Pyrimidinergic receptor P2Y6 [Acc:HGNC:8543]
Acid sensing ion channel subunit 1
[Acc:HGNC:100]
Calcium voltage-gated channel auxiliary subunit
gamma 8 [Acc:HGNC:13628]
Calcium voltage-gated channel subunit alpha1 G
[Acc:HGNC:1394]
Calcium voltage-gated channel subunit alpha1 B
[Acc:HGNC:1389]
Calcium voltage-gated channel subunit alpha1 F
[Acc:HGNC:1393]

Transcript
(RPKM)
0.4
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2

Purinergic receptor P2X 5 [Acc:HGNC:8536]

0.2

Transient receptor potential cation channel
subfamily M member 6 [Acc:HGNC:17995]

0.2

Purinergic receptor P2Y2 [Acc:HGNC:8541]

0.2

Calcium voltage-gated channel subunit alpha1 E
[Acc:HGNC:1392]
Calcium voltage-gated channel auxiliary subunit
beta 1 [Acc:HGNC:1401]
Acid sensing ion channel subunit 3
[Acc:HGNC:101]
Transient receptor potential cation channel
subfamily M member 8 [Acc:HGNC:17961]
Sodium channel epithelial 1 delta subunit
[Acc:HGNC:10601]

0.2
0.2
0.2
0.2
0.2
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ENSG0000013767
2
ENSG0000018238
9
ENSG0000016686
2

Transient receptor potential cation channel
subfamily C member 6 [Acc:HGNC:12338]
Calcium voltage-gated channel auxiliary subunit
beta 4 [Acc:HGNC:1404]
Calcium voltage-gated channel auxiliary subunit
gamma 2 [Acc:HGNC:1406]

0.2
0.1
0.1

